Skip to main content
Caplight Logo









EyeNetra

EyeNetra

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://eyenetra.com

Last Round

Series A

Extension

Jul 28, 2014

Total Funding Raised

$7M

Company Overview

EyeNetra operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A Extension round in July 2014.

EyeNetra is a medical devices company that has developed a smartphone-powered eye diagnostics platform designed to measure the correction of users' vision.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Vertical SaaS, Telemedicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EyeNetra Comparables

Compare EyeNetra with similar companies based on industry and business-model similarity.

EyeNetra comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Smart Vision Labs
86%
PlenOptika
85%
oDocs Eye Care
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EyeNetra Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 28, 2014
Series AJun 26, 2013
SeedJul 26, 2012
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EyeNetra Investors

Notable investors and investment history

EyeNetra investors
InvestorRounds
Khosla VenturesSeries A Extension, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    Monthly visitors increased 151% MoM, reaching 5K.

  • Jul 4, 2025

    Monthly visitors grew 133% MoM, reaching 5.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

EyeNetra Filings

Explore SEC and related filing metadata, where available.

EyeNetra filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EyeNetra's valuation, stock price, and market status.

Is EyeNetra a public or private company?

EyeNetra is a private company.

What is the current stock price of EyeNetra?

EyeNetra is a private company, so its shares have no public market price. Caplight tracks EyeNetra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EyeNetra worth (valuation)?

Valuation information for EyeNetra is not publicly available.

Can I buy EyeNetra stock?

EyeNetra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EyeNetra's last funding round?

EyeNetra's most recent funding round was Series A Extension on July 28, 2014.

Who are the main investors in EyeNetra?

Key investors in EyeNetra include Khosla Ventures.

Will EyeNetra IPO soon?

No public IPO plans have been announced for EyeNetra.

How can I track EyeNetra secondary market activity?

Caplight tracks bids, offers, and trades in EyeNetra's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range8
Year Founded2011
Last FundingJul 28, 2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?